The Patent Finder

Terms ending in 2031

Interpace Diagnostics Corporation

Every in-force patent on Interpace Diagnostics Corporation's record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 10,150,999Mirnas as Biomarkers for Distinguishing Benign from Malignant Thyroid Neoplasms
In force
 · High confidence
Interpace Diagnostics, LLCIn forceHigh confidence
US 11,118,231Mirnas as Biomarkers for Distinguishing Benign from Malignant Thyroid Neoplasms
In force
 · High confidence
Interpace Diagnostics, LLCIn forceHigh confidence
2 of 2 patents shown. Soonest term end first, then patent number.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited